3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Sarcoma
2
Esophageal Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thoracic Diseases
1
Skin Neoplasms
1
Prolactinoma
1
Pituitary ACTH Hypersecretion
1
Paraproteinemias
1
Pancreatic Ductal Adenocarcinoma
1
Nervous System Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Lung Neoplasms
1
Leiomyosarcoma
1
Immunoglobulin Light-chain Amyloidosis
1
Gigantism
1
Endometrial Neoplasms
1
Congenital Abnormalities
1
Combined Pituitary Hormone Deficiency
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Central Nervous System Neoplasms
1
Central Nervous System Diseases
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Radiotherapy
3
Nivolumab
3
pembrolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Paclitaxel
2
ONC206
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Etoposide
2
Cyclophosphamide
2
Carboplatin
2
Biopsy
2
regorafenib
1
pegfilgrastim
1
mirdametinib
1
lutetium Lu 177 dotatate
1
fludarabine
1
etoposide phosphate
1
entrectinib
1
entinostat
1
elacestrant
1
decitabine and cedazuridine drug combination
1
cabozantinib
1
amino-acid, glucose, and electrolyte solution
1
alectinib
1
aflibercept
1
abemaciclib
1
Topotecan
1
Tissue Banks
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Central Nervous System Neoplasms
×
Tissue Banks
×
Clear all
NCT00811148
2026-01-13
FCBTR
University of Florida
Recruiting
4,000 enrolled